Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

Biosimilars: SOP for Use of Single-Use Systems in DSP – V 2.0

Posted on By


Biosimilars: SOP for Use of Single-Use Systems in DSP – V 2.0


Standard Operating Procedure for Use of Single-Use Systems in DSP in Biosimilar Manufacturing

Department Biosimilars
SOP No. SOP/BS/183/2025
Supersedes SOP/BS/183/2022
Page No. Page 1 of 10
Issue Date 04/05/2025
Effective Date 06/05/2025
Review Date 04/05/2026

1. Purpose

To define the procedure for the selection, inspection, assembly, use, and disposal of single-use systems (SUS) in downstream processing (DSP) operations of biosimilar products in accordance with GMP standards.

2. Scope

This SOP applies to all SUS components such as bags, tubing sets, filters, connectors, and pre-sterilized manifolds used during chromatography, filtration, pooling, buffer storage, and final bulk handling operations in DSP.

3. Responsibilities

  • Production: Assemble and verify integrity of SUS components, ensure traceability, and record usage data.
  • Engineering: Support leak and pressure integrity tests of SUS and connect to skid or pump systems.
  • QA: Review and approve SUS lot documentation, ensure correct disposition post-use.

4. Accountability

The Downstream Process Manager is accountable for ensuring validated and GMP-compliant use of single-use assemblies in manufacturing operations.

5. Procedure

5.1 Selection and Receipt of SUS

  1. Select SUS components from approved vendors with validated biocompatibility and extractables/leachables profiles.
  2. On receipt, inspect packaging for damage, verify lot number, sterility status, and CoC/CoA documentation.
  3. Store at designated controlled temperature if applicable (e.g., 15–25°C).

5.2 Assembly and Pre-Use Checks

  1. Assemble SUS in classified area as per validated layout drawing (Annexure-1).
  2. Visually inspect seals, ports, and connectors for defects.
  3. Perform leak test using pressurized air or nitrogen as per supplier specification.
  4. Document assembly lot details in Annexure-2.

5.3 Integration with Process Equipment

  1. Connect SUS to chromatography skid, filtration pump, or pooling tank using validated aseptic connectors.
  2. Ensure flow direction matches process layout and labeling.

5.4 Usage and Monitoring

  1. Monitor pressure, temperature, and flow rate during processing as applicable to operation (e.g., bulk hold or sterile filtration).
  2. Do not reuse SUS; discard after single campaign or lot as per supplier guidelines.

5.5 Post-Use Handling

  1. Disconnect SUS and place in designated biohazard bins after draining residual product.
  2. Record disposal details and batch linkage in Annexure-3.
  3. Send for incineration or validated destruction process as per SOP.

6. Abbreviations

  • SUS: Single-Use System
  • CoC: Certificate of Conformance
  • CoA: Certificate of Analysis
  • DSP: Downstream Processing

7. Documents

  1. SUS Assembly Diagram – Annexure-1
  2. SUS Usage and Lot Traceability Log – Annexure-2
  3. SUS Disposal Log – Annexure-3

8. References

  • ICH Q9 – Quality Risk Management
  • PDA Technical Report 66 – Single-Use Systems
  • WHO TRS 1004 – GMP Guidelines for Biologics

9. SOP Version

Version: 2.0

10. Approval Section

Prepared By Checked By Approved By
Signature
Date
Name
Designation
Department

11. Annexures

Annexure-1: SUS Assembly Diagram

Component Part No. Flow Direction Remarks
Bag – 50L SUS-BAG50L Inlet Product Pool
Tubing Set SUS-TUB202 Outlet To Sterile Filter

Annexure-2: SUS Usage and Lot Traceability Log

Date Batch No. SUS Lot No. Used In Operation Operator
04/05/2025 BS-DSP-081 SUS-2398 Post-Protein A Filtration Sunita Reddy

Annexure-3: SUS Disposal Log

Date SUS Lot No. Disposed By Disposed To Remarks
04/05/2025 SUS-2398 Ajay Verma Biohazard Bin #4 Completely drained

Revision History:

Revision Date Revision No. Details Reason Approved By
04/05/2025 2.0 Added disposal traceability log and pressure leak test verification Audit recommendation
See also  Biosimilars: SOP for Equipment Maintenance Log Review - V 2.0
Biosimilars V 2.0 Tags:biosimilar manufacturing SOP, biosimilar process validation SOP, biosimilar quality control procedure, cell line development SOP biosimilars, chromatography SOP biosimilars, cleaning validation SOP for biosimilar equipment, cleanroom SOP for biologics manufacturing, deviation handling SOP in bioprocess, downstream processing SOP, environmental monitoring SOP biosimilars, GMP SOP for biosimilars, host cell protein removal SOP, inline UV monitoring SOP biosimilars, media preparation SOP for biosimilars, protein purification SOP, purification skid calibration SOP, SOP for bioreactor inoculation biosimilars, SOP for biosimilar cell banking, SOP for cell culture in biosimilar production, SOP for chromatography column packing, SOP for ELISA-based clone screening, SOP for endotoxin testing in biologics, SOP for filter sterilization in downstream processing, SOP for glycosylation analysis in biosimilars, SOP for master cell bank, SOP for protein A chromatography steps, SOP for resin qualification in biosimilar purification, SOP for viral clearance in biosimilar production, SOP for working cell bank, upstream processing SOP biosimilars

Post navigation

Previous Post: Quality Control: SOP for Periodic Calibration of QC Equipment – V 2.0
Next Post: SOP Training Frequency: How Often is Enough?

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme

Go to mobile version